This article first appeared on GuruFocus. Oracle (NYSE:ORCL), the database, cloud and healthcare software company, introduced an electronic health record built for cancer care. Shares were down about 2.4% to $133.77 around 10:16 a.m. ET Monday. Oracle announced the product last week; HTN Health Tech News reported on it Monday. Warning! GuruFocus has detected 6 Warning Signs with ORCL. Is ORCL fairly valued? Test your thesis with our free DCF calculator.ORCL GF Value chart Cancer treatment can leave a clinician piecing together scans, lab results, genomic data and drug histories before making the next call. Oracle wants its oncology system to put that information in one place.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.